Ra Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
RARX Ra Pharmaceuticals Inc
BAC Bank of America Corp
POL PolyOne Corp
MNTA Momenta Pharmaceuticals Inc
LMT Lockheed Martin Corp
HAS Hasbro Inc
JBLU JetBlue Airways Corp
CDNS Cadence Design Systems Inc
IVAC Intevac Inc
HLIT Harmonic Inc
Go

Health Care : Biotechnology | Company profile

Ra Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system. It is developing its lead product candidate, RA101495, a self-administered subcutaneous (SC) injection. RA101495 is injected into the tissue under the skin for the treatment of paroxysmal nocturnal hemoglobinuria (PNH). The Company is also developing RA101495 to treat other debilitating complement-mediated diseases such as generalized myasthenia gravis (gMG) and lupus nephritis (LN). It also focuses on discovery and preclinical programs targeting selective inhibition of other uncontrolled complement pathway factors to treat a variety of ophthalmic, renal and inflammatory diseases. The Company uses its Extreme Diversity platform, macrocyclic peptide chemistry technology which produces synthetic macrocyclic peptides.

Price
Delayed
$46.20
Day's Change
-0.05 (-0.11%)
Bid
--
Ask
--
B/A Size
--
Day's High
46.30
Day's Low
46.15
Volume
(Light)

Today's volume of 705,530 shares is on pace to be much lighter than RARX's 10-day average volume of 3,898,117 shares.

705,530
  • Prev Close
    46.25
  • Today's Open
    46.25
  • Day's Range
    46.15-46.30
  • Avg Vol (10-day)
    3.9M
  • Last (time)
    3:20p ET 10/22/19
  • Last (size)
    100
  • 52-Wk Range
    11.27 - 47.08
    LowHigh
  • (11/13/18 - 10/15/19)
    1.87%
  • 97.8%
  • Market Cap
    2.2B
  • Shares Outstanding
    47.1M
  • -1.95
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • --
  • 95.98
  • (% of float 09/30/19)
    7.32

Latest News

October 17, 2019
1:56 pm ET
Globe Newswire
October 16, 2019
1:12 pm ET
Globe Newswire
October 15, 2019
10:12 am ET
Globe Newswire
October 14, 2019
7:19 am ET
MarketWatch
October 11, 2019
4:19 pm ET
PR Newswire
9:07 am ET
MarketWatch
October 10, 2019
2:52 pm ET
Globe Newswire
2:24 pm ET
PR Newswire
2:21 pm ET
PR Newswire
12:54 pm ET
Globe Newswire
8:12 am ET
PR Newswire
7:18 am ET
MarketWatch
7:00 am ET
PR Newswire
2:28 am ET
MarketWatch
1:22 am ET
BusinessWire
October 02, 2019
7:00 am ET
BusinessWire
September 18, 2019
7:00 am ET
BusinessWire
September 04, 2019
7:14 am ET
BusinessWire
August 21, 2019
7:00 am ET
BusinessWire
August 07, 2019
7:00 am ET
BusinessWire
July 29, 2019
7:57 am ET
MarketWatch
July 26, 2019
10:44 am ET
BusinessWire
May 22, 2019
8:30 am ET
MarketWatch
April 10, 2019
7:47 am ET
MarketWatch
7:25 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.